RBC Raises Price Target on Chemed to $585 From $548
RBC Capital Markets has increased its price target for Chemed Corporation to $585 from $548 while maintaining a Sector Perform rating.
Stocks · News reference
Analysts Adjust Price Targets for Chemed Corporation Following Q3 Earnings
Multiple financial institutions, including RBC, UBS, and Oppenheimer, have updated their price targets for Chemed Corporation following the company's third-quarter 2026 earnings report.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- fiscal.ai
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Oppenheimer Maintains Outperform on Chemed, Raises Price Target to $625
Bank of America Adjusts Chemed Price Target to $555
Bank of America has increased its price target for Chemed Corporation from $550 to $555 while maintaining a Buy rating.